(Q61627994)
Statements
A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma (English)
Jenette Creaney
Arman Hasani
Agatha van der Schaaf
Amanda Segal
Michael J Millward
Ian M Dick
Michael J Byrne
1 September 2012